The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.

HL, Kaufman; JM, Kirkwood; FS, Hodi; S, Agarwala; T, Amatruda; SD, Bines; JI, Clark; B, Curti; MS, Ernstoff; T, Gajewski; R, Gonzalez; LJ, Hyde; D, Lawson; M, Lotze; J, Lutzky; K, Margolin; DF, McDermott; D, Morton; A, Pavlick; JM, Richards; W, Sharfman; VK, Sondak; J, Sosman; S, Steel; A, Tarhini; JA, Thompson; J, Titze; W, Urba; R, White; MB, Atkins

doi:10.1038/nrclinonc.2013.153

Public

The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.

Shared by NobleBlocks on Aug 27, 2013 • 12:00 AM UTC

Authors:

Kaufman HL

Kirkwood JM

Hodi FS

Abstract

Immunotherapy is associated with durable clinical benefit in patients with melanoma. The goal of this article is to provide evidence-based consensus recommendations for the use of immunotherapy in the clinical management of patients with high-risk and advanced-stage melanoma in the USA. To achieve t...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!